Good Manufacturing Practice

Also known as: GMP · Current Good Manufacturing Practice (cGMP / CGMP) · WHO GMP (the WHO guide version) · GMP Clearance (Philippine FDA term for foreign-manufacturer recognition)

Business

Definition

Good Manufacturing Practice (GMP) is the body of quality-assurance requirements that manufacturers of drugs, food, cosmetics, medical devices, and related products must satisfy so that goods are “consistently high in quality, from batch to batch, for their intended use” — with the declared primary purpose of preventing harm to the end user. GMP sets minimum, performance-based requirements rather than prescriptive recipes: manufacturers design their own processes, but must control them through a quality management system covering hygienic and environmentally controlled premises, validated manufacturing processes, written procedures and good documentation practice, trained personnel, quality-control testing, traceable batch and distribution records, complaint and recall systems, and periodic self-inspection. The term current Good Manufacturing Practice (cGMP) denotes conformity with the latest guidelines of the relevant regulator, such as the United States FDA’s regulations under Title 21 of the Code of Federal Regulations. (Wikipedia — Good manufacturing practice, WHO — TRS 986 Annex 2)

At the international level, the reference document is the WHO guide Good manufacturing practices for pharmaceutical products: main principles (Annex 2 of Technical Report Series 986, 2014), which serves as a standard for justifying GMP status, an element of the WHO Certification Scheme on the quality of pharmaceutical products moving in international commerce, a basis for the inspection of manufacturing facilities, and training material for government inspectors; WHO-style GMP is applied in more than 100 countries. In the Philippines, the Food and Drug Administration implements GMP for drug products under Republic Act No. 9711 (the FDA Act of 2009, successor to Republic Act No. 3720 of 1963), through a documented series of issuances traced below. (WHO — TRS 986 Annex 2, FDA Philippines — Revised Guidelines on GMP Clearance, Wikipedia — Good manufacturing practice)

Identities

Source Type	Identity
Wikipedia	Good manufacturing practice
Wikidata	Good manufacturing practice (Q1292017)
DBpedia	Good_Manufacturing_Practice
ProductOntology	N/A
Wiktionary	N/A
Library of Congress Subject Headings (LCSH)	N/A
MeSH	N/A
NCBI Taxonomy	N/A
AGROVOC	N/A
Google Scholar	Good Manufacturing Practice GMP quality assurance pharmaceutical inspection WHO FDA
ConceptNet	N/A
OpenCyc	N/A

Also Known As

GMP
Current Good Manufacturing Practice (cGMP / CGMP)
WHO GMP (the WHO guide version)
GMP Clearance (Philippine FDA term for foreign-manufacturer recognition)

Examples and Analogies

Recipe plus kitchen inspection: Testing a finished sample is like tasting one spoonful of soup; GMP instead inspects the whole kitchen — the premises, the cooks’ training, the written recipe, the cleaning schedule — because a safe batch today proves nothing about tomorrow’s. (Wikipedia — Good manufacturing practice)
A license to make, not just to sell: Under WHO main principles, licensed pharmaceutical products should be manufactured only by licensed manufacturers whose activities are regularly inspected by competent national authorities — manufacturing authorization, not product registration alone, is the gate. (WHO — TRS 986 Annex 2)
The Philippine layering: The Philippine FDA adopted WHO’s GMP guidelines by Administrative Order No. 220 in 1974, upgraded them by AO No. 43 in 1999, adopted the PIC/S GMP guides through AO No. 2012-0008, and now runs a GMP-clearance regime for foreign drug manufacturers under AO No. 2013-0022 — each issuance an ASEAN- and WHO-aligned refresh of the same inspection idea. (FDA Philippines — Revised Guidelines on GMP Clearance)
One member of the GxP family: GMP sits beside GDP (distribution), GLP (laboratory), GCP (clinical), and GVP (pharmacovigilance) practices — each a “good practice” governing one stage of the product life cycle. (Wikipedia — Good manufacturing practice)

Usage Scenarios

1. Licensing and Inspection of Drug Manufacturers

National authorities grant and maintain manufacturing licenses only after GMP inspection; inspections are often unannounced, and in the United States must occur at a “reasonable time” under the federal food-and-drug statute. (Wikipedia — Good manufacturing practice)

2. Foreign-Manufacturer Clearance for Imports

The Philippine FDA requires a GMP Clearance — obtained primarily through desktop assessment and/or on-site inspection by the FDA Drug GMP Inspectorate — before a Certificate of Product Registration can be issued for an imported drug product; a clearance based on inspection is valid for three years from the inspection date. (FDA Philippines — Revised Guidelines on GMP Clearance)

3. Food, Cosmetics, and Dietary Supplements

The same GMP logic extends across regulated consumer products: separate current-GMP rules apply to dietary supplements in the United States (since 2007), and GMP-type hygiene and process-control requirements govern food, beverages, and cosmetics, administered in the Philippines by the FDA’s centers for food, drugs, and cosmetics regulation. (Wikipedia — Good manufacturing practice)

4. Regional Reliance Networks

Philippine GMP rules are anchored to the ASEAN Mutual Recognition Arrangement on GMP inspection — under which the Philippines became the fifth ASEAN Member State listed on 7 January 2020 — and to the PIC/S guides, allowing regulators to rely on one another’s inspections. (FDA Philippines — Revised Guidelines on GMP Clearance)

Strategies

Build the quality management system first: GMP is implemented through a QMS with adequate resources, competent personnel, suitable premises, and appropriate equipment; the written system is what inspectors audit. (Wikipedia — Good manufacturing practice)
Document everything, in real time: Clear written instructions, records demonstrating procedures were followed, and traceable batch documentation are the backbone — if it is not documented, it did not happen. (Wikipedia — Good manufacturing practice)
Qualify, validate, self-inspect: Equipment qualification, process validation, and periodic self-inspection convert GMP from a static checklist into a maintained state of control. (WHO — TRS 986 Annex 2)
Use recognized guides as the baseline: Regulators and manufacturers converge on WHO main principles, the ICH Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients (1999), and PIC/S guides so that one factory can satisfy many markets. (Wikipedia — Good manufacturing practice, FDA Philippines — Revised Guidelines on GMP Clearance)

Security and Safety Measures

Preventive controls against contamination: Hygienic, environmentally controlled facilities and defined processes exist to prevent cross-contamination and mix-ups before any product reaches testing. (Wikipedia — Good manufacturing practice)
Adulteration findings without proof of defect: Products may be deemed adulterated when manufactured under conditions that fail current GMP — even absent a specific defect in the seized batch — making process failure itself the violation. (Wikipedia — Good manufacturing practice)
Traceability and recall capability: Complete batch and distribution records enable targeted recalls, the safety net when prevention fails. (Wikipedia — Good manufacturing practice)
Data integrity emphasis: Regulators including the US FDA and Australia’s TGA have issued guidance stressing data integrity and quality culture, addressing falsified or deleted records in GMP environments. (Wikipedia — Good manufacturing practice)
Inspector training and certification schemes: The WHO guide doubles as training material for government medicines inspectors, and underpins the WHO Certification Scheme used in international commerce. (WHO — TRS 986 Annex 2)

Historical Context

GMP in its modern statutory form emerged from mid-twentieth-century pharmaceutical regulation: the US Food and Drug Administration codified current GMP for drugs, food, devices, and cosmetics under Title 21 CFR, and the approach spread worldwide, with WHO publishing its main-principles guide — now in the 2014 edition as Annex 2 of Technical Report Series 986 — as the reference for its more than 100 member-state users. The 1999 ICH Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients extended GMP to API manufacture across the EU, Japan, and the United States and their adopting partners, and inspection cooperation schemes such as PIC/S harmonized inspectorates. (Wikipedia — Good manufacturing practice, WHO — TRS 986 Annex 2)

In the Philippines, the documented GMP regime begins with Administrative Order No. 220 (13 June 1974), by which the FDA adopted the WHO Guidelines on GMP for pharmaceutical and biological products; this was upgraded by AO No. 43 (1999) and followed by AO No. 2012-0008, which adopted the PIC/S GMP guides as the basis of the ASEAN Mutual Recognition Arrangement on GMP. AO No. 2013-0022 established the current guidelines on cGMP clearance and inspection of foreign drug manufacturers, implemented through FDA Circular No. 2014-016 and the subject of a 2021 draft revision, and the Philippines’ listing under the ASEAN MRA on GMP on 7 January 2020 made its inspection outputs regionally recognizable — the regime that governs the establishments licensed and inspected by the agency profiled in this wiki’s entries on the Food and Drug Administration of the Philippines and on compounded pharmaceutical regulation. (FDA Philippines — Revised Guidelines on GMP Clearance)

Challenges and Controversies

Flexibility Versus Enforceability

Because GMP is performance-based — firms choose their own processes — enforcement leans on judgment: the doctrine that a product is adulterated when made under non-conforming conditions, even without a proven defect, is powerful but contested, since it rests on the state of the factory rather than the safety of the batch. (Wikipedia — Good manufacturing practice)

Data Integrity Failures

Regulatory guidance from the US FDA and the TGA on data integrity and quality culture documents a persistent problem: falsified, deleted, or incomplete records that defeat the documentation backbone of GMP, detected only through deep audits. (Wikipedia — Good manufacturing practice)

Inspection Capacity and Reliance

WHO-style GMP prevails in over 100 countries, many with limited inspectorates; regimes such as the Philippine FDA’s mix of desktop assessment and on-site foreign inspection trade coverage for depth, a compromise acknowledged in the FDA’s own revised-guidelines draft, which reserves on-site inspection for higher-risk cases and accepts reliance on recognized foreign reports where available. (FDA Philippines — Revised Guidelines on GMP Clearance, Wikipedia — Good manufacturing practice)